BROMODOMAIN INHIBITORS

The present invention provides for compounds of formula (I) wherein A 1 , A 2 , A 3 , A 4 , X 1 , X 2 , Y 1 , L 1 , G 1 , R x , and R y have any of the values defined thereof in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases a...

Full description

Saved in:
Bibliographic Details
Main Authors WADA, CAROL K, MCDANIEL, KEITH F, HASVOLD, LISA, LIU, DACHUN, MANTEI, ROBERT A, SHEPPARD, GEORGE S, HOLMS, JAMES H, MCCLELLAN, WILLIAM J, WANG, LE, PRATT, JOHN K, KATI, WARREN M, DAI, YUJIA, FIDANZE, STEVEN D
Format Patent
LanguageEnglish
French
German
Published 05.11.2014
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention provides for compounds of formula (I) wherein A 1 , A 2 , A 3 , A 4 , X 1 , X 2 , Y 1 , L 1 , G 1 , R x , and R y have any of the values defined thereof in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, cancer, and AIDS. Also provided are pharmaceutical compositions comprising one or more compounds of formula (I).
Bibliography:Application Number: EP20120863599